developing the full range of pharmaceutical products for Dr. Max Pharmacy chain
Dr. Max Pharma was established in 2011. Since then the company has demonstrated rapid and sustainable growth. While majority of our portfolio is represented by general Private Label products, we entered also highly sophisticated product segments like the OTC (2013) as well as Premium (2015) ones where we compete with globally established brands.
Although the initial Gx launch took place in 2016, significant growth has been observed in more recent years, particularly in 2022, 2023, and 2024.
Number of SKUs | 1200
*including product in development
Dr. Max Pharma sources the raw materials and finished products globally. Significant number of our partners are located in Europe and Asia.
Global Wide portfolio
across all pharmaceutical product segments
Dr. Max Group is fully owned by Penta Investments, an investment group operating Europe, that has been involved in the healthcare industry since 2002, investing in health insurance, hospitals, outpatient clinics, pharmacies and laboratories. Dr. Max streams of business include pharmacies, wholesale and sales and marketing divisions.
Dr. Max Pharma private label complements the overall value-driven concept and strategy of the Dr. Max Pharmacy, at the centre of whitch are the customers and their needs. Therefore we commit to provide better healthcare experience through the best value-for-money promise delivered by high quality and competetive pricing.
Raw materials and finished products are checked on several levels - by the manufacturer during the production process, and prior to release of the final product to the Dr. Max Pharmacy chain. Thus, the quality control of our products exceeds significantly the quality control standards defined by the regulation.
The individual process steps are carried out in cooperation with dependable partners. Since many of our suppliers certified for the production of pharmaceuticals, they meet the most demanding quality requirements.
Products are distributed from the manufacturer through distribution channels that are used for medicines, whitch ensures safe handling of the products en route from the manufacturer to the pharmacy.
The distribution through the pharmacy chain ensures the products are solely handled by trained and dedicated staff, who can also recommend a suitable product and indicate potential risk of inappropriate combinations of different products.
Send a specific business offer or get information about products.
Dr. Max Pharma, s.r.o.
Na Florenci 2116/15A
110 00 Praha